Abliva: Q2’21: KL1333 Project Progressing - Redeye
Bildkälla: Stockfoto

Abliva: Q2’21: KL1333 Project Progressing - Redeye

Redeye is encouraged by the progress of KL1333 ahead of an expected major capital raise to fund the next pivotal step in clinical development.

Börsvärldens nyhetsbrev